{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:37:11Z","timestamp":1790390231221,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,15]]},"DOI":"10.1093\/infdis\/jir816","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T23:57:15Z","timestamp":1326326235000},"page":"684-692","source":"Crossref","is-referenced-by-count":86,"title":["Noninferiority of Miltefosine Versus Meglumine Antimoniate for Cutaneous Leishmaniasis in Children"],"prefix":"10.1093","volume":"205","author":[{"given":"Luisa Consuelo","family":"Rubiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Consuelo","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Muvdi Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz Mery","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Rodr\u00edguez-Barraquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Garcerant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyda","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ximena","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben Santiago","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Gore Saravia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,1,11]]},"reference":[{"key":"key\n\t\t\t\t20170702153824_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1590\/S0074-02762001000200004","article-title":"Domestic and peridomestic transmission of American cutaneous leishmaniasis: changing epidemiological patterns present new control opportunities","volume":"96","author":"Campbell-Lendrum","year":"2001","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"key\n\t\t\t\t20170702153824_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7705\/biomedica.v26i1.1507","article-title":"Leishmania panamensis transmission in the domestic environment: the results of a prospective epidemiological survey in Santander, Colombia","volume":"26","author":"Munoz","year":"2006","journal-title":"Biomedica"},{"key":"key\n\t\t\t\t20170702153824_bib3","first-page":"365","article-title":"Urbanization: an increasing risk factor for leishmaniasis","volume":"77","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20170702153824_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4269\/ajtmh.2003.68.519","article-title":"Indoor and peridomestic transmission of American cutaneous leishmaniasis in northwestern Argentina: a retrospective case-control study","volume":"68","author":"Yadon","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4269\/ajtmh.2008.78.276","article-title":"Etiologic agent of an epidemic of cutaneous leishmaniasis in Tolima, Colombia","volume":"78","author":"Rodriguez-Barraquer","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-4632.2008.03417.x","article-title":"Treatment of new world cutaneous leishmaniasis\u2014a systematic review with a meta-analysis","volume":"47","author":"Tuon","year":"2008","journal-title":"Int J Dermatol"},{"key":"key\n\t\t\t\t20170702153824_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species","volume":"64","author":"Palacios","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/510860","article-title":"Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate","volume":"195","author":"Cruz","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702153824_bib9","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170702153824_bib10","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170702153824_bib11","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for New World cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702153824_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1086\/648726","article-title":"Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan","volume":"50","author":"van Thiel","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702153824_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","article-title":"Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran","volume":"103","author":"Mohebali","year":"2007","journal-title":"Acta Trop"},{"key":"key\n\t\t\t\t20170702153824_bib14","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1371\/journal.pntd.0000912","article-title":"Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial","volume":"4","author":"Machado","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20170702153824_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4269\/ajtmh.2011.10-0155","article-title":"Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania (Viannia) guyanensis in Manaus, Brazil","volume":"84","author":"Chrusciak-Talhari","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2008.78.210","article-title":"Efficacy of miltefosine for Bolivian cutaneous leishmaniasis","volume":"78","author":"Soto","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4269\/ajtmh.2005.73.272","article-title":"The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine","volume":"73","author":"Yardley","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B","volume":"81","author":"Escobar","year":"2002","journal-title":"Acta Trop"},{"key":"key\n\t\t\t\t20170702153824_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/380638","article-title":"Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India","volume":"38","author":"Bhattacharya","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702153824_bib20","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/BF02763048","article-title":"Miltefosine in children with visceral leishmaniasis: a prospective, multicentric, cross-sectional study","volume":"73","author":"Singh","year":"2006","journal-title":"Indian J Pediatr"},{"key":"key\n\t\t\t\t20170702153824_bib21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.inf.0000066877.72624.cb","article-title":"Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis","volume":"22","author":"Sundar","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170702153824_bib22","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/j.1365-3156.2007.01962.x","article-title":"Short communication: the cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004","volume":"12","author":"Vega","year":"2007","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20170702153824_bib23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.4269\/ajtmh.2002.66.738","article-title":"Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania viannia in Colombia","volume":"66","author":"Saravia","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4269\/ajtmh.1990.42.206","article-title":"Distribution and etiology of leishmaniasis in Colombia","volume":"42","author":"Corredor","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4269\/ajtmh.1998.59.86","article-title":"Epidemiologic, genetic, and clinical associations among phenotypically distinct populations of Leishmania (Viannia) in Colombia","volume":"59","author":"Saravia","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib26","volume-title":"Gu\u00eda para el tratamiento y seguimiento del paciente con leishmaniasis. Convenio 442 de 2008 Versi\u00f3n Final, Colombian Ministry of Social Protection","author":"Instituto Nacional de Salud","year":"2011"},{"key":"key\n\t\t\t\t20170702153824_bib27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4269\/ajtmh.1987.36.489","article-title":"Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods","volume":"36","author":"Weigle","year":"1987","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib28"},{"key":"key\n\t\t\t\t20170702153824_bib29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4269\/ajtmh.1989.41.687","article-title":"A review of the geographic distribution and epidemiology of leishmaniasis in the New World","volume":"41","author":"Grimaldi","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/infdis\/168.3.709","article-title":"Epidemiology of cutaneous leishmaniasis in Colombia: environmental and behavioral risk factors for infection, clinical manifestations, and pathogenicity","volume":"168","author":"Weigle","year":"1993","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702153824_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4269\/ajtmh.2010.10-0060","article-title":"Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis","volume":"83","author":"Velez","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib32","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1086\/322689","article-title":"Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent","volume":"33","author":"Soto","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702153824_bib33","first-page":"733","article-title":"Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management","volume":"3","author":"Sundar","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"key\n\t\t\t\t20170702153824_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/519690","article-title":"Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis","volume":"196","author":"Bhattacharya","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702153824_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","article-title":"Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use","volume":"9","author":"Perez-Victoria","year":"2006","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20170702153824_bib36","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.trstmh.2006.02.009","article-title":"Miltefosine: issues to be addressed in the future","volume":"100","author":"Berman","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702153824_bib37","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A policy for leishmaniasis with respect to the prevention and control of drug resistance","volume":"6","author":"Bryceson","year":"2001","journal-title":"Trop Med Int Health"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/205\/4\/684\/18067257\/jir816.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T06:49:02Z","timestamp":1561186142000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jir816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,11]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,1,11]]},"published-print":{"date-parts":[[2012,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jir816","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,11]]}}}